Investor Quaker Bio Ventures Lp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Quaker Bio Ventures Lp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2017-02-14 13G/A PATI / Patriot Transportation Holding, Inc. 0
2016-02-12 13G/A TBRA / Tobira Therapeutics, Inc. 82,463
2014-02-13 13G PATI / Patriot Transportation Holding, Inc. 2,003,472
2013-09-03 13G TBRA / Tobira Therapeutics, Inc. 1,294,021
2013-02-14 13G/A OCRX / Ocera Therapeutics, Inc. 0
2012-02-14 13G/A FOLD / Amicus Therapeutics, Inc. 1,429,762
2012-02-14 13G OCRX / Ocera Therapeutics, Inc. 2,564,791
2012-02-14 13G/A TNGNQ / Tengion, Inc. 795,103